ATE179422T1 - Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel - Google Patents
Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittelInfo
- Publication number
- ATE179422T1 ATE179422T1 AT94927771T AT94927771T ATE179422T1 AT E179422 T1 ATE179422 T1 AT E179422T1 AT 94927771 T AT94927771 T AT 94927771T AT 94927771 T AT94927771 T AT 94927771T AT E179422 T1 ATE179422 T1 AT E179422T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- derivatives
- chinolonylcarboxamidocephalosporine
- products containing
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX9401427 | 1994-02-25 | ||
| MX9403331 | 1994-05-06 | ||
| MX9403394 | 1994-05-09 | ||
| MX9406681 | 1994-09-01 | ||
| MX9406680 | 1994-09-01 | ||
| MX9406682 | 1994-09-01 | ||
| MX9407838 | 1994-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE179422T1 true ATE179422T1 (de) | 1999-05-15 |
Family
ID=27567169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94927771T ATE179422T1 (de) | 1994-02-25 | 1994-10-07 | Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5728691A (de) |
| EP (1) | EP0746561B1 (de) |
| AT (1) | ATE179422T1 (de) |
| AU (1) | AU7706394A (de) |
| CO (1) | CO4340690A1 (de) |
| DE (1) | DE69418218T2 (de) |
| ES (1) | ES2132430T3 (de) |
| WO (1) | WO1995023153A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996034007A1 (es) * | 1995-04-27 | 1996-10-31 | Laboratorios Aranda, S.A. De C.V. | Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| CN101891680B (zh) | 2004-06-24 | 2014-10-29 | 沃泰克斯药物股份有限公司 | Atp-结合弹夹转运蛋白的调控剂 |
| US7573973B2 (en) * | 2005-05-17 | 2009-08-11 | General Electric Company | Methods and systems to facilitate reducing cone beam artifacts in images |
| CN101374849A (zh) * | 2005-12-24 | 2009-02-25 | 沃泰克斯药物股份有限公司 | 作为abc转运蛋白调控剂的喹啉-4-酮衍生物 |
| DK3219705T3 (da) | 2005-12-28 | 2020-04-14 | Vertex Pharma | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| KR101727762B1 (ko) | 2009-03-20 | 2017-04-17 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법 |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| JP2015511583A (ja) | 2012-02-27 | 2015-04-20 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 薬学的組成物およびその投与 |
| CN107250113B (zh) | 2014-10-07 | 2019-03-29 | 弗特克斯药品有限公司 | 囊性纤维化跨膜传导调节蛋白的调节剂的共晶 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468394A (en) * | 1981-04-02 | 1984-08-28 | Eisai Co., Ltd. | Cephalosporin compounds |
| US4404201A (en) * | 1981-11-13 | 1983-09-13 | Warner-Lambert Company | Cephalosporins |
| ZA874696B (en) * | 1986-07-03 | 1988-01-04 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Acyl derivatives |
| GB8816519D0 (en) * | 1987-07-23 | 1988-08-17 | Ici Plc | Antibiotic compounds |
| EP0366193A3 (de) * | 1988-10-24 | 1992-01-08 | Norwich Eaton Pharmaceuticals, Inc. | Antimikrobielle Quinolonyllactame |
| DE4234078A1 (de) * | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
-
1994
- 1994-10-07 ES ES94927771T patent/ES2132430T3/es not_active Expired - Lifetime
- 1994-10-07 EP EP94927771A patent/EP0746561B1/de not_active Expired - Lifetime
- 1994-10-07 AU AU77063/94A patent/AU7706394A/en not_active Abandoned
- 1994-10-07 WO PCT/IB1994/000304 patent/WO1995023153A1/en not_active Ceased
- 1994-10-07 US US08/693,231 patent/US5728691A/en not_active Expired - Fee Related
- 1994-10-07 AT AT94927771T patent/ATE179422T1/de not_active IP Right Cessation
- 1994-10-07 DE DE69418218T patent/DE69418218T2/de not_active Expired - Fee Related
-
1995
- 1995-02-24 CO CO95007315A patent/CO4340690A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69418218D1 (de) | 1999-06-02 |
| AU7706394A (en) | 1995-09-11 |
| EP0746561B1 (de) | 1999-04-28 |
| CO4340690A1 (es) | 1996-07-30 |
| ES2132430T3 (es) | 1999-08-16 |
| WO1995023153A1 (en) | 1995-08-31 |
| DE69418218T2 (de) | 1999-11-04 |
| US5728691A (en) | 1998-03-17 |
| EP0746561A1 (de) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112111A (en) | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them | |
| BG101209A (bg) | Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди | |
| BG101118A (en) | Therapeutical compounds | |
| NZ284846A (en) | 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof | |
| BG102857A (en) | Antimycotic substance-containing and acetate buffer-containing compositions | |
| BR9713363A (pt) | Epotilonas c, d, e e f, preparação e composições | |
| BR9611400A (pt) | "agentes antimicobiano de benzoxazina". | |
| ES8500932A1 (es) | Procedimiento para la obtencion de acidos quinoloncarboxilicos | |
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| DE69418218D1 (de) | Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel | |
| FI954612L (fi) | Uusia imidatsolidiinejä, jotka on substituoitu heterosyklillä, niiden valmistusmenetelmä ja -välituotetteita, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset | |
| IT8423523A0 (it) | Procedimento e composizione per lapreparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale. | |
| PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
| BG103947A (en) | Derivatives of 9-oxymerythromycin | |
| BG103219A (bg) | Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие | |
| PL329027A1 (en) | Derivatives of benzopyrane exhibiting antagonistic activity in respect to leucotriene | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| WO1996022305A3 (en) | Modified peptides | |
| AU6122994A (en) | Hiv protease inhibitors and their preparation | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| UA48958C2 (uk) | 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі | |
| AU1275401A (en) | Fibrous-liponutritional complexes and compositions containing them | |
| CA2037779A1 (en) | Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t | |
| DE60035133D1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
| ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |